The delays in Republican plans to overhaul Obamacare are helpful to hospital operator Tenet Healthcare Corp, the company’s chief executive officer said on Tuesday, as the timeline shifts further out for any changes to government healthcare payments. Trevor Fetter, CEO of Tenet Healthcare, speaks at the Reuters Health Summit in New York, May 7, 2013.
Category: Healthcare Industry
Life Technologies Corp. v. Promega Corp. and the Absent Presumption Against Extraterritoriality
Guest Post by Tim Holbrook, Professor of Law at Emory University School of Law. Professor Holbrook has written extensively on the extraterritorial application of U.S. patent law.
Trump’s H1-B Visa Crackdown Threatens Cutting-Edge U.S. Medicine
Amgen Inc. and Gilead Sciences Inc., as well as overseas companies with stateside operations, rely on the world’s best scientists and lower-level researchers with scarce expertise. A crackdown on visas for these workers could set back research, including the treatment of cancer, executives said.
Doctor’s FMLA retaliation claim reinstated
A federal appeals court has reinstated a retaliation charged filed by a physician who hired an attorney after her vacation was denied and was put on probation a month later. The 2nd U.S. Circuit Court of Appeals in New York upheld the dismissal of other charges filed by Dr. Chinwe Offor, a neonatologist who is an African-American of Nigerian descent, against Mercy Medical Center in Rockville Centre, New York, including race and national origin discrimination, according to last week’s ruling in Dr. Chinwe Offor v.
Drug company fined $150 million for not reporting suspicious orders
A prescription drug wholesale company was handed a record fine Tuesday on allegations from U.S. regulators for not reporting suspicious orders of painkillers. McKesson Corporation will pay a $150 million fine and stop selling certain drugs in Colorado, Ohio, Florida and Michigan after it avoided its own internal systems to avoid inconsistent or outsize orders of drugs such as oxycodone and hydrocodone that are linked to the national opioid epidemic, the Department of Justice announced on Tuesday.
BRIEF-Vermillion, Aspira Labs receive formal FDA clarification…
* Mazor Robotics received purchase orders for 21 systems during fourth quarter 2016; full year system orders increased by 138 pct to all time record of 62 units Source text for Eikon: Further company coverage:
BRIEF-U.S. FDA approves supplemental New Drug Applications for three Type 2 diabetes medicines
WASHINGTON, Jan 4 U.S. Chief Justice John Roberts will no longer participate in a patent dispute at the Supreme Court involving a unit of Thermo Fisher Scientific Inc after he realized he owns about $175,000 of stock in the company, the court said on Wednesday.
Roberts recuses from patent case after discovering conflict
Supreme Court Chief Justice John Roberts says he will no longer participate in deciding a patent infringement case because he discovered he owns shares in the parent company of one of the parties. Roberts took part in arguments in the dispute between California-based Life Technologies Corp. and Wisconsin-based Promega Corp. on Dec. 6. A letter Wednesday from court clerk Scott Harris says Roberts has learned Life Technologies is owned by Massachusetts-based Thermo Fisher Scientific Inc., and Roberts owns shares valued at about $175,000.
Bragar Eagel & Squire, P.C. Reminds Investors of a Class Action…
Bragar Eagel & Squire, P.C. Reminds Investors of a Class Action Lawsuit Against Impax Laboratories, Inc. and the Lead Plaintiff Deadline of January 9, 2017 Bragar Eagel & Squire, P.C. Reminds Investors of a Class Action Lawsuit Against Impax Laboratories, Inc. and the Lead Plaintiff Deadline of January 9, 2017 Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired Impax Laboratories, Inc. securities between February 20, 2014 and November 3, 2016 .
Gallup’s Top Well-Being Discoveries of 2016
The Gallup-Healthways Well-Being Index provides nearly real-time data on Americans’ well-being across five elements: purpose, social, financial, community and physical. The following are Gallup editors’ picks for the most important health and well-being findings reported in 2016.